Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma.
ESMO Open
; 7(6): 100644, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36463732
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pleural Neoplasms
/
Mesothelioma, Malignant
/
Mesothelioma
Limits:
Adult
/
Aged
/
Aged80
/
Humans
/
Middle aged
Language:
En
Journal:
ESMO Open
Year:
2022
Type:
Article